Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - "RUSTY")

NCT00216762 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00216762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - "RUSTY")
Lead sponsor
Johns Hopkins University
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2006
Completion date
May 31, 2007
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urticaria